CBU
WVE icon

CIBC Bancorp USA’s Wave Life Sciences WVE Stock Holding History

CIBC Bancorp USA’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$87.5K Buy
+11,948
New +$96.7K ﹤0.01% 1367

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIBC Bancorp USA's WVE Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Wave Life Sciences (WVE) in Q3 2025: 11,948 shares worth $87.5K. The stake represents ﹤0.01% of the portfolio and ranks #1367 among its holdings.

189 funds tracked by Wall St. Rank hold WVE as of Q3 2025.

  • CIBC Bancorp USA held 11,948 shares of Wave Life Sciences worth $87.5K as of Q3 2025.
  • Wave Life Sciences was a new CIBC Bancorp USA position in Q3 2025.
  • Wave Life Sciences made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1367 holding.
  • 189 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.